Oral Turanabol's Half Life

Printable View

03-07-2005, 05:30 PM
jbol

Oral Turanabol's Half Life

Anybody know? Same as Var?:unsure:
03-07-2005, 05:41 PM
soo2bhuge

i've read that bodybuilders have taken this up to 5 days before the test. so i would imagine it being no more than 24-48hours.
03-07-2005, 05:43 PM
jbol

Quote:

Originally Posted by soo2bhuge

i've read that bodybuilders have taken this up to 5 days before the test. so i would imagine it being no more than 24-48hours.

Just curious of when to start PCT.
03-07-2005, 05:44 PM
soo2bhuge

i've been wondering the same cause i'm about to start my cycle as well. i have a website, but it's at home, i'll post it once i get it.
by the way, what r u running it with?
03-07-2005, 06:06 PM
lzicc

I have 300 of these coming in for my next cycle and I can't wait to try them. I have heard great things aobut them.

The half life is 16 hours of what I read.

[The pharmacokinetics of Oral-Turinabol in humans]

[Article in German]

Schumann W.

Institut fur Mikrobiologie und experimentelle Therapie (ZIMET), Jena.

Disposition and excretion of the anabolic steroid Oral-Turinabol (1;4-chloro-17 alpha-methyl-androsta-1,4-diene-17 beta-hydroxy-3-one) were investigated in male volunteers. Following single p.o. and i.v. administration of the tritium-labelled compound the plasma concentration courses of total radioactivity (1 and 1-metabolites) and of the unchanged parent drug as well as the urinary excretion were estimated. From these data model independent pharmacokinetic parameters based on statistical moments were calculated. 1 is almost completely absorbed after p.o. administration of 10 mg per volunteer. Peak concentrations of total radioactivity and of 1 in plasma were reached about 3 h p.a. Irregularities observed in the plasma level profile following both p.o. and i.v. administration of 1 are due to a marked enterohepatic circulation. Orally given 1 is subject to a first-pass effect, resulting in a diminished systematic availability. The AUC-ratio of the unchanged drug and the total radioactivity of 1 : 13 shows the predominance of metabolites in plasma. After i.v. administration the disposition of unchanged 1 was found biphasically with a terminal half-life of 16 h. 1 and its metabolites are preferentially excreted via the kidneys. The urinary total radioactivity represented about 60% of the dose following both administrations. Due to its affinity to SHBG 1 is able to compete for the protein binding of testosterone, resulting in an increased plasma level of non protein-bound testosterone.

PMID: 1798729 [PubMed - indexed for MEDLINE]
03-07-2005, 06:22 PM
jbol

Quote:

Originally Posted by lzicc

I have 300 of these coming in for my next cycle and I can't wait to try them. I have heard great things aobut them.

The half life is 16 hours of what I read.

[The pharmacokinetics of Oral-Turinabol in humans]

[Article in German]

Schumann W.

Institut fur Mikrobiologie und experimentelle Therapie (ZIMET), Jena.

Disposition and excretion of the anabolic steroid Oral-Turinabol (1;4-chloro-17 alpha-methyl-androsta-1,4-diene-17 beta-hydroxy-3-one) were investigated in male volunteers. Following single p.o. and i.v. administration of the tritium-labelled compound the plasma concentration courses of total radioactivity (1 and 1-metabolites) and of the unchanged parent drug as well as the urinary excretion were estimated. From these data model independent pharmacokinetic parameters based on statistical moments were calculated. 1 is almost completely absorbed after p.o. administration of 10 mg per volunteer. Peak concentrations of total radioactivity and of 1 in plasma were reached about 3 h p.a. Irregularities observed in the plasma level profile following both p.o. and i.v. administration of 1 are due to a marked enterohepatic circulation. Orally given 1 is subject to a first-pass effect, resulting in a diminished systematic availability. The AUC-ratio of the unchanged drug and the total radioactivity of 1 : 13 shows the predominance of metabolites in plasma. After i.v. administration the disposition of unchanged 1 was found biphasically with a terminal half-life of 16 h. 1 and its metabolites are preferentially excreted via the kidneys. The urinary total radioactivity represented about 60% of the dose following both administrations. Due to its affinity to SHBG 1 is able to compete for the protein binding of testosterone, resulting in an increased plasma level of non protein-bound testosterone.

PMID: 1798729 [PubMed - indexed for MEDLINE]

good info:thumbsup:......thanks bro
03-07-2005, 06:24 PM
lzicc

You bet. Glad I could help bro.
03-07-2005, 08:43 PM
soo2bhuge

i guess i was late with mine. sorry jbol